Mesenchymal stem cell therapy: Two steps forward, one step back - Wikidata - wikimedia - TriplyDB

Mesenchymal stem cell therapy: Two steps forward, one step back

Mesenchymal stem cell therapy: Two steps forward, one step back

http://www.wikidata.org/entity/Q33898653

about

Intracellular aggregation of multimodal silica nanoparticles for ultrasound-guided stem cell implantation.Bone marrow mesenchymal stem cell therapy in ischemic stroke: mechanisms of action and treatment optimization strategies Mesenchymal Stem Cells in Chronic Wounds: The Spectrum from Basic to Advanced Therapy Umbilical Cord Tissue-Derived Cells as Therapeutic Agents Mesenchymal stem cells as a vector for the inflammatory prostate microenvironment Mesenchymal Stem Cell Therapy for Cutaneous Wounds Therapeutic potential of mesenchymal stem cells for oral and systemic diseases Mesenchymal stem cells: immune evasive, not immune privileged A small-molecule screen for enhanced homing of systemically infused cells A causal relation between bioluminescence and oxygen to quantify the cell niche Remote spatiotemporally controlled and biologically selective permeabilization of blood-brain barrier Mimicking the inflammatory cell adhesion cascade by nucleic acid aptamer programmed cell-cell interactions.Mesenchymal stem cells transmigrate between and directly through tumor necrosis factor-α-activated endothelial cells via both leukocyte-like and novel mechanisms Multimodal in vivo imaging reveals limited allograft survival, intrapulmonary cell trapping and minimal evidence for ischemia-directed BMSC homing.Pre-stem cell formation by non-platelet RNA-containing particle fusion.mRNA-engineered mesenchymal stem cells for targeted delivery of interleukin-10 to sites of inflammation.Synthetic control of mammalian-cell motility by engineering chemotaxis to an orthogonal bioinert chemical signal.The neuroprotective effects of human bone marrow mesenchymal stem cells are dose-dependent in TNBS colitis.Zero-order controlled release of BMP2-derived peptide P24 from the chitosan scaffold by chemical grafting modification technique for promotion of osteogenesis in vitro and enhancement of bone repair in vivo.Heterogeneous nuclear ribonucleoprotein A1 interacts with microRNA-34a to promote chondrogenic differentiation of mesenchymal stem cells.Activated omentum slows progression of CKD.Effect of CXCR3/HO-1 genes modified bone marrow mesenchymal stem cells on small bowel transplant rejection A novel albumin-based tissue scaffold for autogenic tissue engineering applications Mesenchymal stromal cells engage complement and complement receptor bearing innate effector cells to modulate immune responses Cell therapy with human MSCs isolated from the umbilical cord Wharton jelly associated to a PVA membrane in the treatment of chronic skin wounds.Stem cell approaches for the treatment of type 1 diabetes mellitus.Paracrine effect of mesenchymal stem cells derived from human adipose tissue in bone regeneration.Adult human adipose tissue contains several types of multipotent cells.Mesenchymal stem cells: Emerging mechanisms of immunomodulation and therapy.Cell-dose-dependent increases in circulating levels of immune effector cells in rhesus macaques following intracranial injection of allogeneic MSCs Stem cell educator therapy and induction of immune balance.Mesenchymal stem or stromal cells: a review of clinical applications and manufacturing practices.Delayed intranasal delivery of hypoxic-preconditioned bone marrow mesenchymal stem cells enhanced cell homing and therapeutic benefits after ischemic stroke in mice.Method for obtaining committed adult mesenchymal precursors from skin and lung tissue Synthetic surface for expansion of human mesenchymal stem cells in xeno-free, chemically defined culture conditions.Mesenchymal chondroprogenitor cell origin and therapeutic potential Cell-surface sensors for real-time probing of cellular environments.The TLR7 agonist Imiquimod promote the immunogenicity of mesenchymal stem cells.Do cryopreserved mesenchymal stromal cells display impaired immunomodulatory and therapeutic properties?Dental follicle cells rescue the regenerative capacity of periodontal ligament stem cells in an inflammatory microenvironment.

P2860

Q24595801-BF1862D2-6817-477D-99E6-F747511CE6A1 Q26740083-3113928F-9EB7-4E50-90E8-C13133879942 Q26748517-66D505E7-EA6A-4B7C-961A-5D8872092655 Q26798214-4682009A-60E9-4D3A-A4BF-CC4ED31B5451 Q26853374-F1557A24-D06D-41F0-88AE-94D161809A63 Q26860887-E3C21564-DB6E-458A-A2BB-5DA2DB97C7AF Q26991746-B189FD6F-2983-49AA-AA0E-91171F6E4D3A Q27003371-88234715-A557-4591-80E6-ED1CC05046EA Q27321219-D32DCE7F-495E-427E-AB70-F88292BCDD84 Q27332197-47812286-D99A-4465-B8B4-E661C68C93DC Q30399021-41F348DB-6CC1-4DB4-A298-F95D9E66BC83 Q30503541-2C45157B-DC34-4E67-BFE1-66177D39093E Q30525829-08D659F6-61CF-424C-B33F-4C4D7DBDAF78 Q30530998-B32013A0-91E8-4C6A-8435-0A8CC85A472B Q30543276-BB5846DE-44F1-49A8-8E49-8BD6BE6139EE Q30548207-BC3D83DD-C5BA-4009-8E1C-1604F3409D30 Q30577136-4D84898C-D50B-4A63-9ED4-CA0062C82FFF Q33577019-9F87393B-5F3C-44EF-8F60-AD7A0B8950EC Q33588145-F0889128-B527-4762-AA9C-3517AACD4FAB Q33623137-435792B0-DB50-4793-8621-9D96C271A836 Q33660533-D18E0491-DBD0-4532-A27D-CBF46AF6ACA3 Q33805883-1844807F-0604-47F0-933E-29E7159FD376 Q33917928-C4A06591-4712-4708-B421-6F593FA9DF95 Q33958064-6E152D81-4A88-4A52-B1F6-CADD5D1A3F73 Q33970350-C93B49E9-4ABA-461C-A164-E4B1D347A4C6 Q34111083-001871D8-5730-4CD9-BFFE-EE12E6F3162E Q34150013-B1AEB17B-740A-4E83-B78B-8731F41702ED Q34165095-5B7B625C-EC05-421A-9D15-E43AC061ED2E Q34259085-1C04BCA9-30AA-4E6C-82E9-31BE40600651 Q34275442-6DAD0411-2DAA-4ED9-B662-0AA72C4CC4B1 Q34290347-E66881F1-DC66-4DDA-B190-A7FF611AA51A Q34422955-D45CB627-FE5F-423B-83EA-82852C1B3168 Q34432396-8F508FCD-DCBE-40E8-8385-F5F2FDB00124 Q34541781-21A73B29-B55B-47FC-BD98-E9B696C54DC4 Q34934863-B460AB9F-55C7-4629-9B28-F29691BCE2B8 Q34971854-FE82640C-4C1F-4A33-85F5-B5396EA7E6F9 Q35185609-06B94793-1AED-4973-AACB-40D5F8C44AA9 Q35186756-69B9FDFB-FDCA-4792-9CA1-4B17136A1918 Q35240062-2F6D7BA5-8D23-4A2C-B8AC-C1850D6F9653 Q35295088-A40EA7F1-B4FF-4DD6-BC87-BE1A1EE7B35D

P2860

Mesenchymal stem cell therapy: Two steps forward, one step back

http://www.wikidata.org/entity/Q33898653

description

2010 nî lūn-bûn

@nan

2010 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի մարտին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Mesenchymal stem cell therapy: Two steps forward, one step back

@ast

Mesenchymal stem cell therapy: Two steps forward, one step back

@en

type

label

Mesenchymal stem cell therapy: Two steps forward, one step back

@ast

Mesenchymal stem cell therapy: Two steps forward, one step back

@en

prefLabel

Mesenchymal stem cell therapy: Two steps forward, one step back

@ast

Mesenchymal stem cell therapy: Two steps forward, one step back

@en

P1433

Q33898653-626FF53E-7881-4E54-A702-AF88318FA625

P1476

Q33898653-F65A77DA-6D46-4F25-AD47-E60201FBD461

P2093

Q33898653-3671F105-FB9E-4C97-8DDB-21D5B981E3E6

Q33898653-405C0BB5-A2E6-4C9A-860C-15CE0CC45827

P2860

Q33898653-0253F58A-597A-414D-9611-2D11D50B1B89

Q33898653-0277BC78-B3BE-42DA-9033-BAA7C541B388

Q33898653-03BE1984-04C8-4D69-8A9C-7127D5A19B78

Q33898653-0A4243E8-289D-4385-A6D7-0B58A444AA52

Q33898653-10343D11-7A34-4771-9EC9-A870319B1D48

Q33898653-13517876-96EB-4762-A84E-598F0EBFDFEC

Q33898653-1FEE233F-FF92-4ECF-AC3E-493779AC5640

Q33898653-25164300-D17D-4091-ABD2-E27560436D3D

Q33898653-310AB74D-743D-4433-A84D-6F9908DCD09C

Q33898653-3EB20C99-5FF4-4EEF-91DB-DB792C568AD1

P304

Q33898653-645D9BAE-B742-44C8-A85B-F2770B478EF2

P31

Q33898653-05FB4A2E-FE36-4774-80FD-5AF63C727FA0

P356

Q33898653-E04C43E7-F800-4AE2-BC20-367B748E61E2

P433

Q33898653-D9847A9B-1B9A-4E15-A6CD-B4BADDFCDE46

P478

Q33898653-D4C10AAE-D397-4682-B23F-B5D91FE421B8

P577

Q33898653-64ED50C0-9CC1-4B05-BFB4-A6E7CED8843B

P5875

Q33898653-FCCA7ACD-558F-4B18-B783-E8E0247FB395

P698

Q33898653-0203B757-4A06-44A2-894A-9C0E984B125E

P932

Q33898653-4EB9FBEB-ADAF-4BBD-ACFD-D5F3F408580D

P356

J.MOLMED.2010.02.005

P1433

Trends in Molecular Medicine

P1476

Mesenchymal stem cell therapy: Two steps forward, one step back

@en

P2093

James Ankrum

http://www.w3.org/2001/XMLSchema#string

Jeffrey M Karp

http://www.w3.org/2001/XMLSchema#string

P2860

Regenerating the heart

A novel secretory tumor necrosis factor-inducible protein (TSG-6) is a member of the family of hyaluronate binding proteins, closely related to the adhesion receptor CD44

Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement

Concise review: mesenchymal stem/multipotent stromal cells: the state of transdifferentiation and modes of tissue repair--current views

Ex vivo glycan engineering of CD44 programs human multipotent mesenchymal stromal cell trafficking to bone

Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study

Mesenchymal stem cells reside in virtually all post-natal organs and tissues

Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells

Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli

Bone marrow stromal cells attenuate sepsis via prostaglandin E(2)-dependent reprogramming of host macrophages to increase their interleukin-10 production

P304

203-209

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.MOLMED.2010.02.005

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

16

http://www.w3.org/2001/XMLSchema#string

P577

2010-03-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

42541261

http://www.w3.org/2001/XMLSchema#string

P698

20335067

http://www.w3.org/2001/XMLSchema#string

P932

2881950

http://www.w3.org/2001/XMLSchema#string